ATNM - Actinium Pharmaceuticals Inc
Close
1.99
0.080 4.020%
Share volume: 331,254
Last Updated: Fri 30 Aug 2024 10:30:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.91
0.08
4.19%
Summary score
22%
Profitability
25%
Dept financing
8%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-58.06%
Return on assets
-34.51%
Return on sales
0%
Return on invested capital
151.08%
Total debt ratio
30.89%
Debt ratio change over timeo
-0.78%
Current Ratio
4.35%
Quick Ratio
0%
Cash Position Ratio
4.2%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-72.65%
Return on assets
-31.77%
Return on sales
0%
Return on invested capital
153.19%
Total debt ratio
33.72%
Debt ratio change over timeo
-0.77%
Current Ratio
6.39%
Quick Ratio
0%
Cash Position Ratio
6.21%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-12.2%
Return on assets
-11.11%
Return on sales
0%
Return on invested capital
166.22%
Total debt ratio
10.09%
Debt ratio change over time
-0.93%
Current Ratio
10.51%
Quick Ratio
0%
Cash Position Ratio
10.32%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-141.23%
Return on assets
-123.91%
Return on sales
0%
Return on invested capital
2.29%
Total debt ratio
-78.34%
Debt ratio change over time
-0.78%
Current Ratio
1.85%
Quick Ratio
0%
Cash Position Ratio
1.68%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ATNM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -58.06% | -3.65% | 12.3% | 6.42% |
| Return on assets | -34.51% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 151.08% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 68% | 61% |
| Total debt ratio | 30.89% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.78% | 224.03% | 6.03% | 1.46% |
| Dept financing | 8% | 50% | 19% | 8% |
| Current Ratio | 6.39% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 6.21% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 23% | 49% | 53% |
| Short-term ratios | ATNM | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -72.65% | -16.17% | 18.05% | 7.63% |
| Return on assets | -31.77% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 153.19% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 35% | 69% | 63% |
| Total debt ratio | 33.72% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | -0.77% | 851.68% | 10.97% | 0.58% |
| Dept financing | 8% | 50% | 21% | 8% |
| Current Ratio | 6.39% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 6.21% | 1.41% | 0.73% | 1.41% |
| Liquididy | 50% | 30% | 24% | 44% |